AI 기반 의료 영상 분석 시장 예측(-2034년) - 구성요소, 영상 진단법, 기술, 워크플로우 단계, 임상 기능, 최종사용자, 지역별 세계 분석

According to Stratistics MRC, the Global AI-Based Medical Imaging Analytics Market is accounted for $3.8 billion in 2026 and is expected to reach $22.5 billion by 2034, growing at a CAGR of 24.9% during the forecast period. AI-Based Medical Imaging Analytics refers to the application of artificial intelligence, machine learning, deep learning, and computer vision algorithms to analyze medical images generated through modalities such as CT, MRI, X-ray, ultrasound, and mammography. These platforms assist radiologists and clinicians in detecting abnormalities, quantifying disease progression, supporting diagnostic decisions, and streamlining radiology workflows.

Market Dynamics:

Driver:

Escalating radiologist shortage and surging medical imaging volumes

Healthcare systems globally face an acute shortage of trained radiologists, exacerbated by exponential growth in imaging study volumes driven by an aging population and expanding chronic disease burden. AI-based imaging analytics platforms address this capacity crisis by automating routine image triage, flagging critical findings for urgent review, and enabling non-radiologist clinicians to access AI-assisted preliminary interpretations. Hospitals and diagnostic centers investing in AI workflows report significant reductions in turnaround time and improved detection rates for conditions such as pulmonary embolism, stroke, and lung nodules, creating compelling return-on-investment arguments for technology adoption.

Restraint:

Regulatory uncertainty and clinical validation requirements

Despite growing clinical evidence supporting AI imaging tools, their adoption is constrained by stringent regulatory approval pathways, particularly for diagnostic AI software classified as medical devices. Obtaining FDA clearance or CE marking requires extensive multi-site clinical validation studies demonstrating performance equivalency or superiority to radiologist interpretation, a process that is time-intensive and costly. Radiologist resistance to algorithmic decision support, liability concerns around AI-generated interpretations, and limited reimbursement pathways for AI-assisted reads further dampen commercialization momentum, particularly among smaller healthcare institutions with constrained technology budgets.

Opportunity:

Expansion of federated learning enabling multi-institutional AI model training

Federated learning is emerging as a transformative approach for developing robust AI imaging models without centralizing sensitive patient data across institutions. By training algorithms locally on distributed datasets and aggregating model parameters rather than raw images, federated architectures address data privacy concerns while enabling AI systems to learn from far larger and more diverse patient populations. Academic medical centers, health systems, and AI companies are forming collaborative networks to build disease-specific models with enhanced generalizability across demographic groups and imaging equipment types, unlocking commercial opportunities in underserved imaging subspecialties.

Threat:

Algorithm bias and performance variability across patient populations

AI imaging models trained predominantly on datasets from specific demographic groups or imaging equipment brands risk underperforming when deployed in clinically diverse settings. Documented cases of algorithmic bias in detecting pathologies across racial, gender, and body habitus groups raise patient safety and equity concerns. Performance degradation on images acquired from lower-specification equipment in resource-limited settings further limits global deployability. Addressing these risks requires continuous model monitoring, prospective validation studies, and regulatory mandates for diversity-aware dataset curation during AI system development and post-market surveillance.

Covid-19 Impact:

The COVID-19 pandemic created an urgent testbed for AI medical imaging applications, particularly in detecting COVID-19 pneumonia patterns on chest CT and X-ray studies. Emergency authorizations from regulatory bodies accelerated clinical deployment of AI imaging tools, demonstrating their value in triaging large patient volumes rapidly. The pandemic also highlighted the importance of scalable, cloud-based imaging analytics platforms capable of remote radiologist access and AI-assisted interpretation. Post-pandemic, health systems are maintaining and expanding AI imaging investments as part of broader digital transformation strategies aimed at improving diagnostic resilience.

The Software segment is expected to be the largest during the forecast period

The software segment commands the largest revenue share within the AI-based medical imaging analytics market, reflecting the dominant commercial model of subscription-based and perpetual license software deployments across hospital networks and diagnostic centers. Diagnostic imaging analytics software and workflow optimization tools are widely adopted to enhance radiologist productivity and reduce missed findings. The high lifetime value of enterprise software contracts, ongoing upgrade revenues, and integration with existing PACS and RIS infrastructure create strong revenue visibility for software vendors. Continuous platform enhancements incorporating generative AI capabilities are sustaining software revenue growth.

The Deep Learning Technology segment is expected to have the highest CAGR during the forecast period

Deep learning is forecast to achieve the highest growth rate among AI imaging technologies, driven by its superior ability to identify complex, multi-dimensional patterns within imaging data that exceed conventional machine learning capabilities. Convolutional neural networks and transformer-based architectures are demonstrating breakthrough performance across radiology subspecialties including neuroradiology, cardiology, and oncology imaging. The availability of large-scale annotated imaging datasets through academic partnerships and federated consortia is accelerating deep learning model development. Increased compute efficiency and cloud GPU accessibility are reducing barriers to deploying deep learning solutions at scale within healthcare organizations.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, North America commands the largest share of the global AI-based medical imaging analytics market, anchored by the concentration of leading AI healthcare companies, world-class academic medical centers, and early regulatory pathways enabling commercial AI imaging product launches. The United States FDA's Digital Health Center of Excellence has streamlined the clearance of AI/ML-enabled medical devices, facilitating faster market entry. High healthcare IT expenditure, widespread adoption of PACS infrastructure, and strong physician awareness of AI imaging capabilities collectively reinforce North America's market leadership throughout the forecast period.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. Asia Pacific is expected to record the highest CAGR in the AI-based medical imaging analytics market, fueled by government-led digital health initiatives in China, Japan, South Korea, and India. China's national AI development strategy explicitly prioritizes medical AI applications, with substantial state investment in AI imaging startups and hospital pilot programs. India's expanding network of diagnostic imaging centers and an acute shortage of specialist radiologists are driving strong commercial demand for AI-assisted diagnostic tools. Regional technology companies are developing locally adapted imaging AI solutions tailored to disease patterns and imaging equipment prevalent across the Asia Pacific healthcare landscape.

Key players in the market

Some of the key players in Global AI-Based Medical Imaging Analytics Market include GE HealthCare, Siemens Healthineers, Philips, Canon Medical Systems, Fujifilm Holdings Corporation, Aidoc, Viz.ai, Lunit, Qure.ai, Infervision, Arterys, Butterfly Network, Enlitic, iCAD, and Tempus AI.

Key Developments:

In March 2026, GE HealthCare announced the commercial launch of an expanded AI imaging suite incorporating deep learning-based anomaly detection across cardiac MRI and chest CT studies, with automated prioritization features designed to flag time-sensitive findings for immediate radiologist review, deployed initially across health systems in the United States and United Kingdom.

In February 2026, Aidoc secured a significant multi-year enterprise agreement with a large hospital network encompassing over 40 facilities to deploy its AI-powered triage and notification platform across emergency radiology workflows, expanding its installed base and reinforcing its market position in AI-enabled critical care imaging analytics.

Components Covered:

• Software
• Hardware
• Services

Imaging Modalitys Covered:

• CT
• MRI
• X-ray
• Ultrasound
• Nuclear Imaging
• Mammography
• Optical Imaging
• Multi-modal

Technologies Covered:

• Machine Learning
• Deep Learning
• Computer Vision
• NLP
• Generative AI
• Federated Learning
• Cloud-based AI

Workflow Stages Covered:

• Image Acquisition
• Image Processing
• Image Interpretation
• Diagnosis Assistance
• Reporting & Documentation
• Treatment Planning
• Follow-up & Monitoring

Clinical Functions Covered:

• CADe
• CADx
• Quantitative Imaging Analysis
• Risk Stratification
• Disease Progression Monitoring
• Predictive & Prognostic Analytics

End Users Covered:

• Hospitals
• Diagnostic Imaging Centers
• Specialty Clinics
• Academic & Research Institutes
• Ambulatory Surgical Centers
• CROs
• Other End Users

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global AI-Based Medical Imaging Analytics Market, By Component

• 5.1 Software
  • 5.1.1 Diagnostic Imaging Analytics Software
  • 5.1.2 Workflow Optimization Software
  • 5.1.3 Reporting & Visualization Software
  • 5.1.4 Predictive Analytics Software
• 5.2 Hardware
  • 5.2.1 AI Accelerators
  • 5.2.2 Imaging Data Storage Systems
  • 5.2.3 Edge Computing Devices
• 5.3 Services
  • 5.3.1 Consulting Services
  • 5.3.2 Integration & Deployment Services
  • 5.3.3 Training & Support Services

6 Global AI-Based Medical Imaging Analytics Market, By Imaging Modality

• 6.1 Computed Tomography (CT)
• 6.2 Magnetic Resonance Imaging (MRI)
• 6.3 X-ray Imaging
• 6.4 Ultrasound Imaging
• 6.5 Nuclear Imaging
• 6.6 Mammography
• 6.7 Optical Imaging
• 6.8 Multi-modal Imaging

7 Global AI-Based Medical Imaging Analytics Market, By Technology

• 7.1 Machine Learning
• 7.2 Deep Learning
• 7.3 Computer Vision
• 7.4 Natural Language Processing (NLP)
• 7.5 Generative AI
• 7.6 Federated Learning
• 7.7 Cloud-based AI Analytics

8 Global AI-Based Medical Imaging Analytics Market, By Workflow Stage

• 8.1 Image Acquisition
• 8.2 Image Processing
• 8.3 Image Interpretation
• 8.4 Diagnosis Assistance
• 8.5 Reporting & Documentation
• 8.6 Treatment Planning
• 8.7 Follow-up & Monitoring

9 Global AI-Based Medical Imaging Analytics Market, By Clinical Function

• 9.1 Computer-Aided Detection (CADe)
• 9.2 Computer-Aided Diagnosis (CADx)
• 9.3 Quantitative Imaging Analysis
• 9.4 Risk Stratification
• 9.5 Disease Progression Monitoring
• 9.6 Predictive & Prognostic Analytics

10 Global AI-Based Medical Imaging Analytics Market, By End User

• 10.1 Hospitals
• 10.2 Diagnostic Imaging Centers
• 10.3 Specialty Clinics
• 10.4 Academic & Research Institutes
• 10.5 Ambulatory Surgical Centers
• 10.6 Contract Research Organizations (CROs)
• 10.7 Other End Users

11 Global AI-Based Medical Imaging Analytics Market, By Geography

• 11.1 North America
  • 11.1.1 United States
  • 11.1.2 Canada
  • 11.1.3 Mexico
• 11.2 Europe
  • 11.2.1 United Kingdom
  • 11.2.2 Germany
  • 11.2.3 France
  • 11.2.4 Italy
  • 11.2.5 Spain
  • 11.2.6 Netherlands
  • 11.2.7 Belgium
  • 11.2.8 Sweden
  • 11.2.9 Switzerland
  • 11.2.10 Poland
  • 11.2.11 Rest of Europe
• 11.3 Asia Pacific
  • 11.3.1 China
  • 11.3.2 Japan
  • 11.3.3 India
  • 11.3.4 South Korea
  • 11.3.5 Australia
  • 11.3.6 Indonesia
  • 11.3.7 Thailand
  • 11.3.8 Malaysia
  • 11.3.9 Singapore
  • 11.3.10 Vietnam
  • 11.3.11 Rest of Asia Pacific
• 11.4 South America
  • 11.4.1 Brazil
  • 11.4.2 Argentina
  • 11.4.3 Colombia
  • 11.4.4 Chile
  • 11.4.5 Peru
  • 11.4.6 Rest of South America
• 11.5 Rest of the World (RoW)
  • 11.5.1 Middle East
    • 11.5.1.1 Saudi Arabia
    • 11.5.1.2 United Arab Emirates
    • 11.5.1.3 Qatar
    • 11.5.1.4 Israel
    • 11.5.1.5 Rest of Middle East
  • 11.5.2 Africa
    • 11.5.2.1 South Africa
    • 11.5.2.2 Egypt
    • 11.5.2.3 Morocco
    • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

• 12.1 Industry Value Network and Supply Chain Assessment
• 12.2 White-Space and Opportunity Mapping
• 12.3 Product Evolution and Market Life Cycle Analysis
• 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

• 13.1 Mergers and Acquisitions
• 13.2 Partnerships, Alliances, and Joint Ventures
• 13.3 New Product Launches and Certifications
• 13.4 Capacity Expansion and Investments
• 13.5 Other Strategic Initiatives

14 Company Profiles

• 14.1 GE HealthCare
• 14.2 Siemens Healthineers
• 14.3 Philips
• 14.4 Canon Medical Systems
• 14.5 Fujifilm Holdings Corporation
• 14.6 Aidoc
• 14.7 Viz.ai
• 14.8 Lunit
• 14.9 Qure.ai
• 14.10 Infervision
• 14.11 Arterys
• 14.12 Butterfly Network
• 14.13 Enlitic
• 14.14 iCAD
• 14.15 Tempus AI